Recordati Group
Clinical trials sponsored by Recordati Group, explained in plain language.
-
New hope for kids with rare hormone disorder
Disease control Recruiting nowThis study is testing a drug called osilodrostat in children and teenagers (ages 2 to 18) with Cushing's syndrome, a rare condition caused by too much of the stress hormone cortisol. The main goal is to understand how the child's body processes the drug and to see if it safely lo…
Phase: PHASE2 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Global effort launches to track rare blood disorder
Knowledge-focused Recruiting nowThis study is creating a global registry to collect real-world information about people with Cold Agglutinin Disease, a rare autoimmune blood disorder. Researchers will follow 400 patients over time to understand how the disease progresses, what treatments work best, and how it a…
Sponsor: RECORDATI GROUP • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC